Article
A single nucleotide polymorphism in the carboxylesterase gene is associated with the responsiveness to imidapril medication and the promoter activity.
Hypertension research : official journal of the Japanese Society of Hypertension - 1 Sept 2005
Geshi Eiichi, Kimura Tomomi, Yoshimura Mika, Suzuki Hiroshi, Koba Shinji, Sakai Tetsuo, Saito Tsukasa, Koga Atsuro, Muramatsu Masaaki, Katagiri Takashi
Abstract excerpt
Imidapril is an angiotensin-converting enzyme inhibitor that is widely used in treating hypertension, although the responses vary among individuals. We investigated whether a single nucleotide polymorphism at position -816 of the carboxylesterase 1 (CES1) gene, which activates imidapril in the liver, is involved in the responsiveness to imidapril medication. A total of 105 Japanese hypertensives with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
